S Chevaliez

Summary

Country: France

Publications

  1. ncbi request reprint Clinical utility of hepatitis C virus core antigen quantification in patients with chronic hepatitis C
    Stephane Chevaliez
    National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hopital Henri Mondor, Universite Paris Est, Creteil, France INSERM U955, Creteil, France Electronic address
    J Clin Virol 61:145-8. 2014
  2. doi request reprint Performance of a new rapid test for the detection of hepatitis B surface antigen in various patient populations
    Stephane Chevaliez
    National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hopital Henri Mondor, Universite Paris Est, Creteil, France INSERM U955, Creteil, France Electronic address
    J Clin Virol 59:89-93. 2014
  3. doi request reprint Is HBsAg quantification ready, for prime time?
    Stephane Chevaliez
    INSERM U955, Department of Virology, Universite Paris Est, French National Reference Center for Viral Hepatitis B, C and delta, Hopital Henri Mondor, 51, Avenue du Marechal de Lattre de Tassigny, 94010 Creteil, France Electronic address
    Clin Res Hepatol Gastroenterol 37:559-63. 2013
  4. doi request reprint Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: finite treatment duration unlikely
    Stephane Chevaliez
    National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hopital Henri Mondor, Universite Paris Est, Creteil, France
    J Hepatol 58:676-83. 2013
  5. pmc The Cobas AmpliPrep/Cobas TaqMan HCV test, version 2.0, real-time PCR assay accurately quantifies hepatitis C virus genotype 4 RNA
    Stephane Chevaliez
    National Reference Center for Viral Hepatitis B, C, and Delta, Department of Virology, Hopital Henri Mondor, Universite Paris Est, Creteil, France
    J Clin Microbiol 51:1078-82. 2013
  6. pmc Performance of version 2.0 of the Cobas AmpliPrep/Cobas TaqMan real-time PCR assay for hepatitis B virus DNA quantification
    Stephane Chevaliez
    National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hopital Henri Mondor, Universite Paris Est, Creteil, France
    J Clin Microbiol 48:3641-7. 2010
  7. doi request reprint Role of class I human leukocyte antigen molecules in early steps of echovirus infection of rhabdomyosarcoma cells
    Stephane Chevaliez
    Unité de Biologie des virus entériques, Institut Pasteur, Paris, France
    Virology 381:203-14. 2008
  8. doi request reprint Mechanisms of non-response to antiviral treatment in chronic hepatitis C
    Stephane Chevaliez
    National Reference Center for Viral Hepatitis B, C and delta, Department of Virology and INSERM U955, Hopital Henri Mondor, Universite Paris Est, Creteil, France
    Clin Res Hepatol Gastroenterol 35:S31-41. 2011
  9. doi request reprint Virological tools to diagnose and monitor hepatitis C virus infection
    S Chevaliez
    French National Reference Centre for Viral Hepatitis B, C and delta, Department of Virology and INSERM U955, Hopital Henri Mondor, Universite Paris Est, Creteil, France
    Clin Microbiol Infect 17:116-21. 2011
  10. ncbi request reprint IL28B polymorphisms and chronic hepatitis C
    S Chevaliez
    French National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hopital Henri Mondor, Université Paris Est Créteil, 51, Avenue du Marechal de Lattre de Tassigny, 94010 Creteil, France
    Gastroenterol Clin Biol 34:587-9. 2010

Collaborators

Detail Information

Publications27

  1. ncbi request reprint Clinical utility of hepatitis C virus core antigen quantification in patients with chronic hepatitis C
    Stephane Chevaliez
    National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hopital Henri Mondor, Universite Paris Est, Creteil, France INSERM U955, Creteil, France Electronic address
    J Clin Virol 61:145-8. 2014
    ..HCV core antigen can now be easily detected and quantified by means of a chemiluminescent microparticle immunoassay on the Abbott Architect device...
  2. doi request reprint Performance of a new rapid test for the detection of hepatitis B surface antigen in various patient populations
    Stephane Chevaliez
    National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hopital Henri Mondor, Universite Paris Est, Creteil, France INSERM U955, Creteil, France Electronic address
    J Clin Virol 59:89-93. 2014
    ..They represent a promising alternative to enzyme immunoassays and a powerful tool for large-scale screening and diagnosis of HBV infection, especially in regions without easy access to serological and molecular testing...
  3. doi request reprint Is HBsAg quantification ready, for prime time?
    Stephane Chevaliez
    INSERM U955, Department of Virology, Universite Paris Est, French National Reference Center for Viral Hepatitis B, C and delta, Hopital Henri Mondor, 51, Avenue du Marechal de Lattre de Tassigny, 94010 Creteil, France Electronic address
    Clin Res Hepatol Gastroenterol 37:559-63. 2013
    ....
  4. doi request reprint Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: finite treatment duration unlikely
    Stephane Chevaliez
    National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hopital Henri Mondor, Universite Paris Est, Creteil, France
    J Hepatol 58:676-83. 2013
    ..The aim of the present study was to assess whether finite nucleoside/nucleotide analogue treatment duration could be envisaged during the patient's lifetime...
  5. pmc The Cobas AmpliPrep/Cobas TaqMan HCV test, version 2.0, real-time PCR assay accurately quantifies hepatitis C virus genotype 4 RNA
    Stephane Chevaliez
    National Reference Center for Viral Hepatitis B, C, and Delta, Department of Virology, Hopital Henri Mondor, Universite Paris Est, Creteil, France
    J Clin Microbiol 51:1078-82. 2013
    ..In conclusion, CAP/CTM HCV v2.0 accurately quantifies HCV RNA in genotype 4 clinical specimens, regardless of the subtype, and can be confidently used in clinical trials and clinical practice with this genotype...
  6. pmc Performance of version 2.0 of the Cobas AmpliPrep/Cobas TaqMan real-time PCR assay for hepatitis B virus DNA quantification
    Stephane Chevaliez
    National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hopital Henri Mondor, Universite Paris Est, Creteil, France
    J Clin Microbiol 48:3641-7. 2010
    ..Overall, the CAP/CTM assay, version 2.0, is well suited to monitoring clinical HBV DNA levels according to current clinical practice guidelines...
  7. doi request reprint Role of class I human leukocyte antigen molecules in early steps of echovirus infection of rhabdomyosarcoma cells
    Stephane Chevaliez
    Unité de Biologie des virus entériques, Institut Pasteur, Paris, France
    Virology 381:203-14. 2008
    ..In conclusion, HLA class I molecules are involved in the early steps of EV11 infection of RD cells and appear to participate in a complex interplay of surface molecules acting as coreceptors, including DAF...
  8. doi request reprint Mechanisms of non-response to antiviral treatment in chronic hepatitis C
    Stephane Chevaliez
    National Reference Center for Viral Hepatitis B, C and delta, Department of Virology and INSERM U955, Hopital Henri Mondor, Universite Paris Est, Creteil, France
    Clin Res Hepatol Gastroenterol 35:S31-41. 2011
    ..The goal of this review is to discuss mechanisms involved in the non-response to current and future standard treatments...
  9. doi request reprint Virological tools to diagnose and monitor hepatitis C virus infection
    S Chevaliez
    French National Reference Centre for Viral Hepatitis B, C and delta, Department of Virology and INSERM U955, Hopital Henri Mondor, Universite Paris Est, Creteil, France
    Clin Microbiol Infect 17:116-21. 2011
    ....
  10. ncbi request reprint IL28B polymorphisms and chronic hepatitis C
    S Chevaliez
    French National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hopital Henri Mondor, Université Paris Est Créteil, 51, Avenue du Marechal de Lattre de Tassigny, 94010 Creteil, France
    Gastroenterol Clin Biol 34:587-9. 2010
    ..More information is now needed to understand the mechanisms that underlie this association...
  11. ncbi request reprint Hepatitis C virus: virology, diagnosis and management of antiviral therapy
    Stephane Chevaliez
    French National Reference Center for Viral Hepatitis B, C and delta, Department of Virology and INSERM U 841, Hopital Henri Mondor, 94010 Creteil, France
    World J Gastroenterol 13:2461-6. 2007
    ..e. the endpoint of therapy...
  12. pmc Seroconversion to hepatitis C virus alternate reading frame protein during acute infection
    Yoann Morice
    National Reference Center for Viral Hepatitis B, C, and Delta, Department of Virology, Henri Mondor Hospital, University of Paris 12, Creteil, France
    Hepatology 49:1449-59. 2009
    ..No difference was found between the patients who did and did not seroconvert to alternate reading frame protein...
  13. ncbi request reprint Determinant roles of environmental contamination and noncompliance with standard precautions in the risk of hepatitis C virus transmission in a hemodialysis unit
    Emmanuelle Girou
    Infection Control Unit, Henri Mondor Hospital, Creteil, France
    Clin Infect Dis 47:627-33. 2008
    ..A prospective observational study was conducted to assess the roles of environmental contamination and noncompliance with standard precautions in HCV cross-transmission in a hemodialysis unit...
  14. ncbi request reprint The hepatitis C virus life cycle as a target for new antiviral therapies
    Jean Michel Pawlotsky
    French National Reference Center for Viral Hepatitis B, C, and Delta, Department of Virology, Hopital Henri Mondor, Universite Paris 12, Creteil, France
    Gastroenterology 132:1979-98. 2007
    ....
  15. doi request reprint Care of hepatitis C virus infection in human immunodeficiency virus-infected patients: modifications in three consecutive large surveys between 2004 and 2009
    Patrice Cacoub
    Universite Pierre et Marie Curie PARIS6, CNRS, UMR 7211, France
    J Hepatol 53:230-7. 2010
    ..To analyze the care of HCV infection in HIV-HCV coinfected patients and its progression between 2004 and 2009...
  16. pmc Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice
    Stephane Chevaliez
    French National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hopital Henri Mondor, Universite Paris 12, Creteil, France
    PLoS ONE 4:e8209. 2009
    ..The goal of this study was to identify the appropriate molecular tool(s) for accurate HCV genotype 1 subtype determination...
  17. ncbi request reprint Use of virologic assays in the diagnosis and management of hepatitis C virus infection
    Stephane Chevaliez
    Department of Virology, INSERM U635, Henri Mondor Hospital, University of Paris XII, 51 Avenue du Marechal de Lattre de Tassigny, 94010 Creteil, France
    Clin Liver Dis 9:371-82, v. 2005
    ..The continuing development of test systems accompanied by new antiviral drugs and novel therapeutic approaches should lead to an optimization of the treatment of HCV infection...
  18. doi request reprint How to use virological tools for optimal management of chronic hepatitis C
    Stephane Chevaliez
    Department of Virology and INSERM U841, French National Reference Center for Viral Hepatitis B, C and delta, Hopital Henri Mondor, Universite Paris 12, Creteil, France
    Liver Int 29:9-14. 2009
    ..Thus, virological assays are indispensable in the diagnosis and management of individuals infected with the HCV...
  19. pmc Analysis of ribavirin mutagenicity in human hepatitis C virus infection
    Stephane Chevaliez
    Department of Virology, Hopital Henri Mondor, Universite Paris 12, Creteil, France
    J Virol 81:7732-41. 2007
    ..This study strongly undermines the hypothesis whereby ribavirin acts as an HCV mutagen in vivo...
  20. ncbi request reprint Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method
    Stephane Chevaliez
    French National Reference Center for Viral Hepatitis B, C, and Delta, Department of Virology, Hopital Henri Mondor, Creteil, France
    Hepatology 46:22-31. 2007
    ....
  21. pmc Characterization of V36C, a novel amino acid substitution conferring hepatitis C virus (HCV) resistance to telaprevir, a potent peptidomimetic inhibitor of HCV protease
    Laetitia Barbotte
    Department of Virology, Hopital Henri Mondor, France
    Antimicrob Agents Chemother 54:2681-3. 2010
    ..5-fold increase in the replicon model. The replication capacity of a replicon harboring V36C was close to that of the wild-type protease. This case emphasizes the complexity of hepatitis C virus resistance to protease inhibitors...
  22. pmc Performance of the Abbott real-time PCR assay using m2000sp and m2000rt for hepatitis C virus RNA quantification
    Stephane Chevaliez
    French National Reference Center for Viral Hepatitis B, C, and Delta, Department of Virology, Hopital Henri Mondor, Universite Paris 12, and INSERM U955, 94010 Creteil, France
    J Clin Microbiol 47:1726-32. 2009
    ....
  23. doi request reprint Diagnosis and management of chronic viral hepatitis: antigens, antibodies and viral genomes
    Stephane Chevaliez
    Department of Virology and INSERM U955, French National Reference Centre for Viral Hepatitis B, C and delta, Hopital Henri Mondor, Universite Paris, Creteil, France
    Best Pract Res Clin Gastroenterol 22:1031-48. 2008
    ..The HCV genotype and on-treatment viral kinetics can be used to tailor treatment dosages and duration...
  24. ncbi request reprint Interferon-based therapy of hepatitis C
    Stephane Chevaliez
    French National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hopital Henri Mondor, Universite Paris 12, Creteil, France
    Adv Drug Deliv Rev 59:1222-41. 2007
    ..Finally, insights into new hepatitis C drug developments are given...
  25. ncbi request reprint Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily
    Christophe Hezode
    Department of Hepatology and Gastroenterology, Hopital Henri Mondor, Assistance Publique Hopitaux de Paris, Universite Paris XII, Creteil, France
    J Hepatol 46:791-6. 2007
    ..Some patients receiving adefovir at the approved dose of 10 mg daily for chronic hepatitis B have a "suboptimal" virological response characterized by a slow and moderate decrease in viral replication...
  26. pmc Performance of the Cobas AmpliPrep/Cobas TaqMan real-time PCR assay for hepatitis B virus DNA quantification
    Stephane Chevaliez
    French National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Hopital Henri Mondor, Universite Paris 12
    J Clin Microbiol 46:1716-23. 2008
    ..Samples with HBV DNA concentrations above the upper limit of quantification need to be diluted and then retested. Broad use of fully automated real-time PCR assays should improve the management of patients with chronic HBV infection...